In line with emerging evidence for a possible correlation between TIL PD-L1 expression and response to anti–PD-1 therapy [10,11], assessment of that patient’s tumor revealed PD-L1–positive infiltrating macrophages and lymphocytes [18]. This evidence concerns the gene CD274 and neoplasm.